Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Influenza and Other Respiratory Viruses|November 28, 2025
Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network StudyJames Humphreys, Nathalie Nicolay, Toon Braeye, et al.Plos Medicine|March 8, 2011
Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control studyMarta Valenciano, Esther Kissling, Jean-Marie Cohen, et al.Influenza and Other Respiratory Viruses|January 22, 2021
Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020Esther Kissling, Mariëtte Hooiveld, Mia Brytting, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 29, 2016
I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?Esther Kissling, Baltazar Nunes, Chris Robertson, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 20, 2026
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026Heloise Lucaccioni, Diogo Fp Marques, Freja Kirsebom, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 5, 2019
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohortEsther Kissling, Francisco Pozo, Silke Buda, et al.Epidemiology and Infection|March 16, 2025
Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23Susana Monge, James Humphreys, Nathalie Nicolay, et al.Influenza and Other Respiratory Viruses|April 24, 2024
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network StudySusana Monge, James Humphreys, Nathalie Nicolay, et al.IJID Regions|June 15, 2023
Primary series COVID-19 vaccine effectiveness among healthcare workers in Albania, February-December 2021Julia E Rubin-Smith, Madelyn Yiseth Rojas Castro, Iria Preza, et al.Plos One|November 24, 2011
I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in EuropeEsther Kissling, Marta Valenciano, Jean Marie Cohen, et al.Pageof 7